1Crouse JR, Harpold GH,Kahl FR,et al. Evaluation of a scoring system for extracranial carotid atherosclerosis extent with B mode ultrasound[J]. Stroke, 1986,17(2) : 270-275.
3Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men[J]. N Engl J Med,1997,336(14):973-979.
4Ridker PM, Buring JE, Shih J, et al. Prospective study of C- reactive protein and the risk of future cardiovascular events among apparently healthy women [J]. Circulation, 1998, 98 (8) :731-733.
5Verma S, Li SH, Badiwala MV, et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein[J]. Circulaiton, 2002, 105 (16) : 1890-1896.
6Cottone S, Mule G, Nardi E, et al. C-reactive protein and intercellular adhesion molecule-1 are stronger predictors of oxidant stress than blood pressure in established hypertension [J].J Hypertens,2007,25(2) :423-428.
7Pasceri V, Cheng JS, Willerson JT, et al. Modulation of C- reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs[J]. Circulation,2001,103(21):2531-2534.
8Hattori Y, Matsumura M, Kasai K. Vascular smooth muscle cell activation by C-reactive protein[J]. Cardiovasc Res, 2003, 58(1) :186-195.
10Zwaka TP, Hombach V, Torzewski J. C-reactive proteinmediated low density lipoprotein uptake by macrophages: implications for atherosclerosis [J]. Circulation, 2001,103 (9) : 1194-1197.
二级参考文献30
1[1]Jabs WJ, Logering BA, Gerke P, et al. Kidney as a second site of human C-reactive protein formation in vivo. Eur J immunology, 2003, 33 152～161.
2[2]Woo P, Korenberg JR, Whitehead AS, et al. Characterizaton of genomic and complementary DNA sequence of human C-reactive protein,and comparison with the complementary DNA sequence of serum amyloid P component. J Biol Chem,1989,260 13384～13388
3[3]Shrive AK, Gheetham GM,Holden D, et al. Three dimention structure of C-reactive protein. Nature Struc Biol,1996,3 346～354.
4[4]Angrawal A, Lee S, Carson M, et al. Site-directed mutagenesis of the phosphocholine-binding site of human C-reactive protein. J Immunol,1997,166 3998～4004.
5[5]Bharadwaj D,Stein MP,Volzer M, et al. The major receptor for C-reactive protein on leukorcyte is FcgRII .J Exp Med,1999,190 585～590
7[7]Liuzzo G,Biasucci LM,Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med, 1994,331 417～424.
8[8]Biasucci LM,Liuzzo G,Grillo RL, et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predicts recurrent instability.Circulation,1999,99 855～860.
9[9]Gaspardone A,Grea F,Versaci F, et al. Predictive value of C-reactive protein after successful coronary artery stenting in patients with stable angina. Am J Cardiol,1998,82 515～518.
10[10]Ridker PM,Cushman M,Stampfer MJ, et al. Inflammation,aspirin,and the risk of cardiovascular disease in apparently healthy men. N Engl J Med,1997,336 973～979.
